LexDanaLexDanabeta
Inventor

MARINA GELMAN

Inventor
US

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07DHeterocyclic compounds43%
A61KPreparations for medical, dental or toiletry purposes14%
PatentTitleYear
12,227,508TGF-b inhibitors202511,466,018TGF-b inhibitors202211,352,360TGF-beta inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to RIGEL PHARMACEUTICALS INC (3)· patent assignee history
2022Patents assigned to BRISTOL MYERS SQUIBB CO (1)· patent assignee history
2022Patents assigned to RIGEL PHARMACEUTICALS HIC (1)· patent assignee history
2022–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RIGEL PHARMACEUTICALS INC32022–2025
BRISTOL MYERS SQUIBB CO12022
RIGEL PHARMACEUTICALS HIC12022
Locations
LocationPatentsSpan
US32022–2025